मैगज़्टर गोल्ड के साथ असीमित हो जाओ
10,000 से अधिक पत्रिकाओं, समाचार पत्रों और प्रीमियम कहानियों तक असीमित पहुंच प्राप्त करें सिर्फ
कोशिश गोल्ड - मुक्त
As cost of weight loss drug soars, fears that those who need it most will be left behind
The Observer
|August 31, 2025
The price of Mounjaro doubles tomorrow but appetite for the injections does not appear to be shrinking
The first of the new wave of weight-loss drugs was approved for treatment in the UK nearly two decades ago, offering hope to type-2 diabetes patients who needed to lose weight.
"I've been prescribing these drugs since 2007," says Dr Stephen Lawrence, a GP and associate clinical professor in diabetes at the University of Warwick. Initially, clinicians thought that patients would be reluctant to inject themselves. "But what we found was that people said: 'You had me at weight loss'
Glucagon-like peptide-1 (GLP-1) receptor agonists are now household names through their brands Ozempic, Wegovy, and Mounjaro, and are being used by more than 1.5 million people in the UK, not just to treat diabetes but also for general weight loss.
They entered public consciousness in 2022, when
यह कहानी The Observer के August 31, 2025 संस्करण से ली गई है।
हजारों चुनिंदा प्रीमियम कहानियों और 10,000 से अधिक पत्रिकाओं और समाचार पत्रों तक पहुंचने के लिए मैगज़्टर गोल्ड की सदस्यता लें।
क्या आप पहले से ही ग्राहक हैं? साइन इन करें
The Observer से और कहानियाँ
The Observer
Can a biopic of the Boss be anything other than blinded by his light?
Heavens above, not another biopic. I'm still in recovery from A Complete Unknown, James Mangold’s attempted unveiling of The Mysterious Soul of Bob Dylan starring Timothy Someone-or-other.
2 mins
October 26, 2025
The Observer
Reeves is still only getting part of the Brexit message
The financial markets, and much of the media, seem obsessed by the level of public sector debt and borrowing.
3 mins
October 26, 2025
The Observer
The anonymous Twitter troll account set up to discredit Virginia Giuffre
The online attacks came thick and fast, all 479 of them designed to discredit the accuser of Epstein, Maxwell and Prince Andrew.
5 mins
October 26, 2025
The Observer
Badenoch and Farage should stop playground politics of making rules they can't keep
Do unto others as you would have them do unto you. That's the golden rule I remember being taught as a child in primary school. Not a bad guiding principle.
3 mins
October 26, 2025
The Observer
Museums are in the pink while corporate sponsors remain shy
By embracing private philanthropy, the sector has received record sums, however businesses are feeling burnt by protests, write Nicole Fan and Stephen Armstrong
3 mins
October 26, 2025
The Observer
'Democrat saviour' or 'commie bastard': Mamdani, would-be king of New York
The 34-year-old socialist set to become the Big Apple's first Muslim mayor may be the left's greatest hope - and biggest threat. Hugh Tomlinson joins the new star of US politics on the campaign trail
8 mins
October 26, 2025
The Observer
Use Russia's money
Europe has missed its chance to hit Putin's finances
2 mins
October 26, 2025
The Observer
Struggling 'clean food' brands dig in for long haul
Autumn, season of mists and mellow fruitfulness, wrote Keats. Not if you're in the plant-based food industry. Sales at major brands, including Oatly and Beyond Meat, are stalling.
2 mins
October 26, 2025
The Observer
Reeves mission: to build a European Silicon Valley centred on 'golden triangle'
Brexit is costing the UK 80bn a year in lost taxes, hitting output by up to 8% and investment by more than twice as much. The chancellor has her work cut out
5 mins
October 26, 2025
The Observer
Academics sign letter of support after ‘vile’ abuse of Israeli professor
Tom Watson, Margaret Hodge, Michael Grade, Prof Andrew Roberts and hundreds of academics are among more than 1,600 signatories of an open letter condemning a “targeted harassment campaign” against an Israeli professor at a London university.
1 mins
October 26, 2025
Listen
Translate
Change font size